Navigation Links
Innosight Board Member Honored With Lifetime Achievement Award
Date:6/19/2012

Boston, MA (PRWEB) June 19, 2012

Innovation consulting firm Innosight announced that board member Roy Davis is the recipient of a lifetime achievement award from Global Corporate Venturing Magazine. The magazine’s annual Awards Gala and Symposium recognizes individuals and organizations for their contributions to the venture community, successful portfolio launches and sales, and industry leadership. Accepting the “Industry Legend” award, Davis was lauded for his prolific career with Johnson & Johnson and his dedication to developing new companies under the J&J banner that deliver transformational healthcare solutions.

The award celebrates Davis’ nearly three decades at Johnson & Johnson. Most recently serving as president of Johnson & Johnson Development Corporation (JJDC), he identified early market indicators, healthcare trends and strategic investment opportunities. He also led the creation of Red Script™ Ventures, designed to support the growth of external ventures and internal innovation. Under Davis’ leadership, JJDC, the venture capital subsidiary of J&J, fostered a culture of collaboration, dedicated focus, and milestone management with portfolio companies to improve the investments’ short- and long-term financial outcomes.

As a newly appointed member of Innosight’s board of directors, Davis offers a global perspective and a rich understanding of the healthcare industry. The authority on disruptive innovation, Innosight has deep healthcare expertise, helping pharmaceutical companies, medical device manufacturers and healthcare service providers leverage new business models and solutions that redefine healthcare delivery in markets around the world.

Davis also serves as a member of the Industrial Advisory Board of the Cleveland Clinic, and sits on Rosetta Genomics’ board of dir
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
2. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
3. GenturaDx Announces Formation of Scientific Advisory Board
4. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
5. DiaTech Life Sciences Announces Medical Advisory Board
6. BioStorage Technologies Appoints New Member to Board of Directors
7. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
8. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
9. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
10. Coalition to Save Pure Files Proxy Documents With SEC, Urges Pures Board to Set an Annual Meeting Date
11. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Innosight Board Member Honored With Lifetime Achievement Award
(Date:10/20/2014)... Convey Computer , the leader in ... State University won first place in the 2014 ... the team’s solution achieved the highest overall performance in ... place finisher. , Experts from all segments of the ... challenge, using a variety of design tools, hardware and ...
(Date:10/20/2014)... , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Horovitz , Ph.D., from its board of directors effective on ... August 2003, and served as its chairman from June 2006 ... the Nominating and Corporate Governance and Audit Committees of the ... than a decade of dedicated service to GenVec, and its ...
(Date:10/20/2014)... 20, 2014 Local veterinary surgeon, Dr. ... investigational study of donor stem cells for dogs with ... therapy and has performed clinical stem cell therapy for ... to determine if a single injection of donor stem ... help reduce pain and inflammation in the treated joints. ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The ... bromine market in Asia-Pacific with analysis and forecast ... the Asia Pacific Bromine Market report, to get ... also provides a glimpse of the segmentation in ... various tables and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
... with drug-eluting,stents must take a combination of aspirin ... year, and possibly longer, after stent,implantation. This is ... today in the journals of the Society for ... (ACC), and,American Heart Association (AHA). To access the ...
... Oral Presentation of the US Oncology Adjuvant Trial ... Symposium Showed Taxotere(R) and Cyclophosphamide ... SAN ANTONIO, Dec. 13 Results presented ... (SABCS) showed that for,women with early stage breast ...
... the premier,online community for the medical device ... edition of the US Device(TM) Hotbed,Campaign. DeviceSpace.com ... event, company and other valuable information specific ... The US Device(TM),Hotbed campaign features both a ...
Cached Biology Technology:PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents 2PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents 3PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents 4Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 2Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 3Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 4Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 5DeviceSpace.com Launches Marketing Campaign for US Medical Device Industry 2
(Date:10/18/2014)... genetic conditions, a certain type of exome sequencing method ... traditional molecular diagnostic methods, according to a study appearing ... to coincide with the American Society of Human Genetics ... region of the genome (the complete set of genes ... has been rapidly applied in research settings and recent ...
(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... respiratory tract infections and worldwide claims the lives ... and Ghent University have succeeded in developing a ... infection. , Xavier Saelens (VIB/UGent): "We discovered ... for the development of a novel approach to ... in numerous small children and elderly people." , ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Modeling tumor dormancy 2New perspectives for development of an RSV vaccine 2
... the body regulates blood pressure in response to daily ... helping people whose pressure is out of control. ... pressure is not controlled despite the best efforts of ... director of the Georgia Prevention Institute at the Medical ...
... Jabra BT530 First Product to Feature Noise Blackout(TM), ... the world leader in,innovative headset solutions, today unveiled ... Blackout(TM) reduces ambient sound,without compromising voice quality, providing ... of a natural sounding voice. The Jabra,BT530, shipping ...
... as a flavor enhancer in their food are more likely than ... though they have the same amount of physical activity and total ... Hill School of Public Health study published this month in the ... studied more than 750 Chinese men and women, aged between 40 ...
Cached Biology News:Blood pressure response to daily stress provides clues for better hypertension treatment 2Blood pressure response to daily stress provides clues for better hypertension treatment 3Blood pressure response to daily stress provides clues for better hypertension treatment 4Blood pressure response to daily stress provides clues for better hypertension treatment 5Blood pressure response to daily stress provides clues for better hypertension treatment 6GN Netcom Introduces Innovative Noise Blackout Technology 2GN Netcom Introduces Innovative Noise Blackout Technology 3UNC researchers find MSG use linked to obesity 2
Capture faint-light images without losing sensitivity or resolution. With its brand new hardware and interface design, the LAS-1000plus turns sample imaging into a simple process....
... Hamamatsu C9136 FLIM system combines the space and ... the resolution of the optical microscope to open ... short, pulsed light source for excitation, the decay ... the lifetime of the decay measured. Subtle ...
...
SDS-OutT Precipitation Reagent...
Biology Products: